Bausch Health Companies (BHC) Times Interest Earned (2009 - 2026)
Bausch Health Companies (BHC) posted Times Interest Earned of $0.27 for Q2 2026, up 175.35% sequentially from -$0.35 in Q1 2026, and down 72.19% YoY from $0.95 in Q2 2025.
Bausch Health Companies (BHC) Times Interest Earned (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Times Interest Earned for 18 years, with the latest figure at $0.27 in Q2 2026.
- Quarterly Times Interest Earned fell 72.19% year-over-year to $0.27 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $0.32 (down 66.47% YoY) and the FY2025 annual result came in at $0.7, up 3.98% from the prior year.
- Times Interest Earned improved to $0.27 in Q2 2026 per BHC's latest filing, from -$0.35 in the prior quarter.
- Over five years, Times Interest Earned peaked at $1.66 in Q4 2024 and troughed at -$0.77 in Q4 2022.
- A 5-year average of $0.5 and a median of $0.48 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned slumped 170.38% in 2022, then surged 3391.27% in 2024.
- Over 5 years, Times Interest Earned stood at -$0.77 in 2022, then surged by 182.91% to $0.64 in 2023, then jumped by 159.8% to $1.66 in 2024, then decreased by 27.89% to $1.19 in 2025, then plunged by 77.76% to $0.27 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.27, -$0.35, and $1.19 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.13 Bn | 39.47 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.55 Bn | 29.88 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.73 Bn | 11.20 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.58 Bn | 738.25 Mn | 2.10 Bn | 1.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27 |
| Mar 31, 2026 | 1.72 |
| Dec 31, 2025 | 1.19 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.84 |
| Dec 31, 2024 | 1.66 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 1.09 |
| Sep 30, 2021 | 0.71 |